Burden of gram-positive bacteria from urinary tract infection: A four-year retrospective study in a tertiary health setting in southern Saudi Arabia

沙特阿拉伯南部一家三级医疗机构开展的一项为期四年的回顾性研究:泌尿道感染中革兰氏阳性菌的负担

阅读:1

Abstract

BACKGROUND: Antibiotic resistance is a worldwide problem causing significant health-related and economic losses. Gram-positive causes of urinary tract infections (UTIs) are usually underestimated or overlooked by physicians. AIM: To examine the prevalence of antibiotic resistance among major gram-positive bacteria from UTIs in a tertiary care health hospital in southern Saudi Arabia. METHOD: A cross-sectional retrospective study was done in a tertiary health setting in southern Saudi Arabia between 2019 and 2022, to identify the major gram-positive bacteria and antibiotic resistance. Data were collected from the hospital records and was analyzed using the SPSS statistical package. RESULTS: The most common gram-positive species were Enterococcus faecalis (44.7%), Staphylococcus aureus (15.1%), and Enterococcus faecium (12.9%), beta-hemolytic streptococci (8.4%), and methicillin-resistant Staphylococcus aureus (MRSA) (1.8%). The 1540 isolates showed an overall susceptibility of 71.0%, compared to a resistance of 29.0%. The most resistance was among Enterococcus faecium (54.5%), Enterococcus gallinarum (42.4%), Enterococcus faecalis (34.3%), and MRSA (27.2%). The most common resistance was to erythromycin (75.7%), followed by cefotaxime (73.9%), tetracycline (70.5%), ciprofloxacin (54.3%), and Synercid (53.6%). The prediction model indicates an increase in the prevalence of resistance in MRSA and, to a lesser extent, with E. faecalis, E. faecium, and beta-hemolytic streptococci. CONCLUSIONS: Enterococcus faecalis was the predominant gram-positive species, surpassing Staphylococcus aureus. Almost remarkable resistance was observed to most of the antibiotics that are frequently used in the study area, mainly erythromycin, cefotaxime, and tetracycline. Performing continuous monitoring of drug susceptibility may help with the empirical treatment of bacterial agents in the region.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。